Inke S.A.

About Inke S.A.

Inke S.A. is focused on the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes, mainly for use in Respiratory. Based in Barcelona (Spain) and counting more than twenty years’ experience in micronization, Inke is in continuous international expansion since 1998, delivering APIs all over the world, including US, Europe and Japan. Inke develops, patents and implements its own synthesis routes for the manufacture of active substances. We also specialize in Contract Manufacturing Organization (CMO) services.

  • ES
  • 2017
    On CPHI since
  • 100 - 249
    Employees
Company types
Other
Contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from Inke S.A. (5)

  • Aclidinium bromide

    Product Aclidinium bromide

    Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Aclidinium. Indication: COPD treatment
  • Aprepitant

    Product Aprepitant

    Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Aprepitant. Indication: Emesis

  • Arformoterol tartrate polymorph A and D

    Product Arformoterol tartrate polymorph A and D

    Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Arformoterol tartrate. Indication for COPD 

    US and CN DMF available
  • Asenapine maleate

    Product Asenapine maleate

    Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Asenapine. Indications: Schizophrenia and acute mania

  • Carvedilol

    Product Carvedilol

    Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Carvedilol. Indications: hypertension, angina and heart failure


    JP DMF available

Inke S.A. Resources (1)

  • Brochure INKE PORTFOLIO AND PIPELINE

    Inke is a Barcelona-based company with an FDA approved plant, we develop and manufacture APIs with complex synthesis process mostly for Respiratory diseases (Inhalation) and also CNS , among other therapeutically areas.

     
    INKE has several DMFs approved already in the US-FDA and we are already supplying to some local and multinational pharmaceutical companies worldwide.